DNAH10 and small cell lung carcinoma: Another study focused on cisplatin-resistant target genes and genes associated with poor prognosis in SCLC, and the results indicated that DNAH10 mutations were significantly associated with cisplatin resistance, poor OS, and worse PFS in SCLC [12].